1. School of Medicine, Barwon Health, Deakin University, IMPACT SRC (Innovation in Mental and Physical Health and Clinical Treatment – Strategic Research Centre), Geelong, Australia;
2. Department of Psychiatry, University of Melbourne, Melbourne, Australia;
3. Mental Health Drug and Alcohol Services, University Hospital Geelong, Barwon Health, Geelong, Australia;
4. Orygen The National Centre of Excellence in Youth Mental Health, Parkville, Australia;
5. School of Psychiatry, University of New South Wales, and Black Dog Institute, Sydney, Australia;
6. Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische, Universität Dresden, Dresden, Germany;
7. Department of Psychiatry, University of British Columbia, British Columbia, BC, Canada;
8. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK & South London and Maudsley NHS Foundation Trust, London, UK;
9. Department of Psychiatry, University of Toronto, Toronto, ON, Canada;
10. Department of Psychiatry & Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA, USA;
11. Department of Psychiatry, Universidad de Antioquia, Medellín, Colombia;
12. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA;
13. Division of Clinical Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;
14. Duke-National University of Singapore Medical School, Singapore, Singapore;
15. Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada;
16. Brain and Cognition Discovery Foundation, Toronto, ON, Canada;
17. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, PA, USA;
18. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wien, Austria
19. The Florey Institute of Neuroscience and Mental Health, Parkville, Australia;